| 1 |
34920170 | Modulating physicochemical properties of tetrahydropyridine-2-amine BACE1 inhibitors with electron-withdrawing groups: A systematic study. | 2022 Jan 15 |
1 |
| 2 |
30709653 | New evolutions in the BACE1 inhibitor field from 2014 to 2018. | 2019 Mar 15 |
1 |
| 3 |
31413800 | Evaluation of a Series of β-Secretase 1 Inhibitors Containing Novel Heteroaryl-Fused-Piperazine Amidine Warheads. | 2019 Aug 8 |
1 |
| 4 |
29809004 | Optimization of 1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors Toward a Clinical Candidate. | 2018 Jun 28 |
1 |
| 5 |
28710924 | Identification of new BACE1 inhibitors using Pharmacophore and Molecular dynamics simulations approach. | 2017 Sep |
2 |
| 6 |
26140617 | A Versatile Approach to CF3 -Containing 2-Pyrrolidones by Tandem Michael Addition-Cyclization: Exemplification in the Synthesis of Amidine Class BACE1 Inhibitors. | 2015 Aug 10 |
1 |
| 7 |
24704031 | The evolution of amidine-based brain penetrant BACE1 inhibitors. | 2014 May 1 |
2 |
| 8 |
23683349 | Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story. | 2013 Jun |
2 |
| 9 |
22998419 | Conformational restriction approach to β-secretase (BACE1) inhibitors: effect of a cyclopropane ring to induce an alternative binding mode. | 2012 Oct 25 |
1 |
| 10 |
20043696 | Discovery of cyclic acylguanidines as highly potent and selective beta-site amyloid cleaving enzyme (BACE) inhibitors: Part I--inhibitor design and validation. | 2010 Feb 11 |
1 |